Dermavant Sciences, an Organon company vs OrsoBio
Dermavant Sciences, an Organon company
A Passion for Science and a Commitment to Dermatology
161 employees · est. 2016 · Long Beach, United States
OrsoBio
Advancing first-in-class therapies to restore energy homeostasis
18 employees · est. 2021 · Palo Alto, United States
Dermavant Sciences, an Organon company is the older company (2016 vs 2021); Dermavant Sciences, an Organon company is the larger of the two.
Side-by-Side Comparison
| Metric | Dermavant Sciences, an Organon company | OrsoBio |
|---|---|---|
| Founded | ||
| Founded | 2016 older | 2021 |
| Headquarters | ||
| Headquarters | Long Beach, United States | Palo Alto, United States |
| Employees | ||
| Employees | 161 larger | 18 |
| Industry | ||
| Industry | Biotechnology, Health Care | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Private Equity | Series A |
| Total Funding | ||
| Total Funding | $160.00M | $62.30M |
| Funding Rounds | ||
| Funding Rounds | 1 | 2 |
| Services | ||
| Services | Development and distribution of women's health medicines and devices, Provision of biosimilars, Offering established brands across multiple therapeutic areas, Healthcare solutions for specific women-related conditions | Developing first-in-class therapies, Targeting energy metabolism pathways, Restoring energy homeostasis |
| Target Customers | ||
| Target Customers | Women across all stages of life, Healthcare professionals, Healthcare systems, Patients requiring cardiovascular, neurological, dermatological, respiratory, and reproductive health solutions | Patients with severe metabolic disorders, Individuals with obesity and diabetes, Healthcare providers focused on metabolic health |
| Taxonomy | ||
| Taxonomy | BiopharmaceuticalDermatologyPrescription TherapiesDermatologic DiseasesTherapeutic NeedsR&D Pipeline +8 | First-in-class TherapiesEnergy HomeostasisMetabolic DisordersType 2 DiabetesSevere DyslipidemiasLipodystrophies +9 |
| Website | ||
| Website | dermavant.com | orsobio.com |
About Dermavant Sciences, an Organon company
Dermavant Sciences, an Organon company, operates within the Biotechnology and Health Care industries. Founded in 2016 and headquartered in the United States, Dermavant has carved a niche in the specialty biopharmaceutical sector by focusing on cutting-edge therapies for dermatologic diseases. The c...
About OrsoBio
OrsoBio, founded in 2021, is a United States-based, clinical-stage biopharmaceutical company aiming to transform the treatment of severe metabolic disorders. Guided by its slogan, "Advancing first-in-class therapies to restore energy homeostasis", the company focuses on innovative treatments for con...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches Dermavant Sciences, an Organon company and OrsoBio for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when Dermavant Sciences, an Organon company or OrsoBio moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare Dermavant Sciences, an Organon company with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Dermavant Sciences, an Organon company on 4 Feb 2026, and OrsoBio on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
